Product Information
BUMETANIDE 2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1749 per EA under NDC 16571067701. Its NADAC has been published 68 times since Mar 12, 2025.
Strength
2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212019On Market Since
6/3/2024
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 2 MG TABLET has been published 68 times since Mar 12, 2025, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1749 per EA |
|---|---|
| All-time high | $0.2674 (Apr 16, 2025) |
| All-time low | $0.1749 (Jun 17, 2026) |
| 52-week high | $0.2544 |
| 52-week low | $0.1749 |
| Median price | $0.2198 |
| Average price | $0.2161 |
| Largest weekly change | -11.7% (Nov 19, 2025) |
| Weeks tracked | 68 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1749 per EA (NDC 16571067701), effective Jun 24, 2026.
How has the price of BUMETANIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 31.1%. It has been tracked across 68 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?
Since Mar 12, 2025, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1749 (Jun 17, 2026) to a high of $0.2674 (Apr 16, 2025), with a median of $0.2198 per EA.
Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BUMETANIDE 2 MG TABLET, but none are currently priced below it.
Who manufactures BUMETANIDE 2 MG TABLET?
BUMETANIDE 2 MG TABLET (NDC 16571067701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification